MENLO PARK, Calif., Sept. 8 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it will present at the Thomas Weisel Partners Healthcare Conference 2009 in Boston, Mass., on Wednesday, September 9, 2009, at 1:30 p.m. EDT in the Blaxton Room of the Four Seasons Hotel.
The presentation will be made by Joseph D. Keegan, Ph.D., ForteBio's president and chief executive officer.
ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com.
CONTACT: Jack Fuchs, Chief Financial Officer ForteBio, Inc. 650-322-1360 Jfuchs@fortebio.com
|SOURCE ForteBio, Inc.|
Copyright©2009 PR Newswire.
All rights reserved